Abstract
In order to reassess the value of quantitative thallium-201 brain SPECT in the differentiation of miscellaneous brain tumors, we studied a total of 89 patients—35 pre-operative patients suspected of having a brain tumor and 54 post-operative patients with a brain tumor. We came to the conclusion that quantitative Tl-201 brain SPECT was very useful in discriminating cerebral radiation necrosis from recurrent tumor, estimating residual tumor burden, and detecting tumor regrowth earlier in postoperative patients. In preoperative patients, however, Tl-201 SPECT cannot be used effectively to differentiate glioma from other intracranial tumors, although intense uptake of Tl-201 may provide evidence of glioblastoma or a hypervascular lesion.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Graeb DA, Steinbok P, Robertson WD: Transient early computed tomographic changes mimicking tumor progression after brain tumor irradiation.Radiology 144: 813–817, 1982
Brismar J, Robertson GH, Davis KR, et al: Radiation necrosis of the brain. Neuroradiological considerations with computed tomography.Neuroradiology 12: 109–113, 1976
Martins AN, Johnson JS, Henry JM, et al: Delayed radiation necrosis of the brain.J Neurosurg 47: 336–345, 1977
Doom GC, Hecht S, Brant-Zawadzki M, et al: Brain radiation necrosis: MR imaging.Radiology 158: 149–155, 1986
Tsuruda JS, Kortman KE, Bradley WG, et al: Radiation effects on cerebral white matter: MR evaluation.AJR 149: 165–171, 1987
Chamberlain MC, Murovic JA, Levin VA: Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas.Neurology 38: 1371–1374, 1988
Di Chiro G, Oldfield E, Wright DC, et al: Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuro-pathological studies.AJNR 8: 1083–1091, 1987
Doyle WK, Budinger TF, Valk PE, et al: Differendation of cerebral radiation necrosis from tumor recurrence by F-18-FDG and Rb-82 positron emission tomography.J Comput Assis Tomogr 11: 563–570, 1987
Mineura K, Sasajima T, Kowada M, et al: Innovative approach in the diagnosis of gliomatosis cerebri using carbon-11-L-methionine positron emission tomography.J Nucl Med 32: 726–728, 1991
Ancri DA, Basset JY, Lonchampt MF, et al: Diagnosis of cerebral lesions by thallium 201.Radiology 128:417–422, 1978
Kaplan WD, Takvorian T, Morris JH, et al: Thallium-201 brain tumor imaging: a comparative study with pathological correlation.J Nucl Med 28: 47–52, 1987
Black KL, Hawkins RA, Kim KT, et al: Use of thallium-201 SPECT to quantitate malignancy grade of gliomas.J Neurosurg 71: 342–346, 1989
Mountz JM, Raymond PA, McKeever PE, et al: Specific localization of thallium-201 in human high-grade astrocytoma by microautoradiography.Cancer Res 49: 4053–4056, 1989
Kim KT, Black KL, Marciano D, et al: Thallium-201 SPECT imaging of brain tumors: Methods and results.J Nucl Med 31: 965–969, 1990
Schwartz RB, Carvalho PA, Alexander III E, et al: Radiation necrosis vs high-grade recurrent glioma: Differentiation by using dual-isotope SPECT with201Tl and99mTc-HMPAO.AJR 158: 399–404, 1992
McKusick KA, Fischman AJ, Hochberg FH, et al: Tl-201 and F-18 deoxyglucose in detection of recurrent primary brain tumor.J Nucl Med 32: p955 (abstract), 1991
Kosarov LB, Friedman H: Enhanced Na+-K+-activated adenosine triphosphatase activity in transforming fibroblast.Cancer Res 34: 1862–1865, 1974
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kosuda, S., Fujii, H., Aoki, S. et al. Reassessment of quantitative thallium-201 brain SPECT for miscellaneous brain tumors. Ann Nucl Med 7, 257–263 (1993). https://doi.org/10.1007/BF03164707
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03164707